Provenance du réseau au premier degré de Feng Zhang
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 16 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Feng Zhang via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| CELGENE | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Founder Private Equity Investor | |
ARCH Venture Partners LP
 ARCH Venture Partners LP Investment ManagersFinance Part of ARCH Venture Partners LLC, ARCH Venture Partners LP operates as a venture capital firm. The company is based in Dover, DE. The company was founded by Robert Taylor Nelsen. | Investment Managers | Founder Corporate Officer/Principal | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Founder | |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Epirium Bio, Inc. develops therapeutics for orphan and rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems. The company was founded in 2008 by Alan Stewart Maisel, Sundeep Dugar, and Francisco Villarreal and is headquartered in Los Altos Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
LearnZillion, Inc.
 LearnZillion, Inc. Miscellaneous Commercial ServicesCommercial Services LearnZillion, Inc. engages in the development of a web-based education tool and video library of math and literacy lessons. LearnZillion was founded by Eric Westendorf and Alix Guerrier in 2011 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
Trelys, Inc.
 Trelys, Inc. Chemicals: SpecialtyProcess Industries Trelys, Inc. owns and operates biotechnology products. The company was founded by Jay Kouba and is headquartered in Hayward, CA. | Chemicals: Specialty | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
| University of Pennsylvania | College/University | Graduate Degree | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
| Boston College | College/University | Undergraduate Degree | |
| Stonehill College, Inc. | College/University | Undergraduate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Easton Associates LLC
 Easton Associates LLC Miscellaneous Commercial ServicesCommercial Services Part of Guidehouse LLP, Easton Associates LLC is a management consulting company that provides services to the healthcare industry. The company is based in New York, NY. The company was founded by Robert J. Easton, Michelle Hasson. Easton Associates was acquired by Guidehouse, Inc. (Virginia), part of Guidehouse LLP from October 11, 2019 on October 02, 2012 for $12.10 million. | Miscellaneous Commercial Services | Consultant / Advisor | |
Novartis Bioventure Fund
 Novartis Bioventure Fund Investment ManagersFinance Novartis Bioventure Fund focuses on companies operating in the field of life science technology. The geographical focus includes the US, Canada, UK and Switzerland. The fund invests in biotechnology, pharmaceuticals and medical device products. It invests in all stages of financing and also invests in mezzanine transactions. | Investment Managers | Corporate Officer/Principal | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
Novartis Venture Fund
 Novartis Venture Fund Investment ManagersFinance Novartis Venture Fund provides early stage venture capital to companies in Europe, North America and Asia. The fund's focus is on the development of novel therapeutics and platforms, therefore it focuses on such sectors as Biotechnology and Biopharma. The fund makes seed and early stage investments ranging up to USD 30 million per company over its life. The fund makes follow-on and co-investments. | Investment Managers | Corporate Officer/Principal | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
AgBiome INC
 AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | Biotechnology | Director/Board Member | |
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
| DENALI THERAPEUTICS INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Founder Director/Board Member | |
| Columbia University College of Pharmaceutical Sciences | College/University | Graduate Degree | |
| GOSSAMER BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Director/Board Member | |
| MODERNA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BOUNDLESS BIO, INC. | Biotechnology | Director/Board Member | |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Autobahn Therapeutics, Inc.
 Autobahn Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Autobahn Therapeutics, Inc. is a thyromimetics drug discovery company. It serves patients with neurodegenerative disorders. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
RBNC Therapeutics, Inc.
 RBNC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology RBNC Therapeutics, Inc. develops and commercializes therapies for individuals with brain diseases. | Pharmaceuticals: Major | Director/Board Member | |
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Pharmaceuticals: Major | Founder Founder | |
Treeline Biosciences, Inc.
 Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Biotechnology | Founder Founder | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
Pretzel Therapeutics, Inc.
 Pretzel Therapeutics, Inc. BiotechnologyHealth Technology Pretzel Therapeutics, Inc. is an American biotechnology company that develops therapies by utilizing mitochondrial biology. Pretzel Therapeutics is based in an undisclosed location and has research facilities in another undisclosed location. The company aims to develop treatments that address the genetic causes of mitochondrial dysfunction. The company was founded by academic experts in mitochondrial biology and is supported by a world-class investor syndicate. Jay Parrish has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
| METACRINE, INC. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 49 |
| Suisse | 2 |
Sectorielle
| Health Technology | 28 |
| Consumer Services | 9 |
| Finance | 7 |
| Commercial Services | 6 |
| Energy Minerals | 2 |
Opérationnelle
| Director/Board Member | 117 |
| Corporate Officer/Principal | 37 |
| Independent Dir/Board Member | 30 |
| Founder | 21 |
| Undergraduate Degree | 10 |
Relations les plus connectées
| Insiders | |
|---|---|
| Robert Nelsen | 80 |
| Kristina Burow | 40 |
| Mark Fishman | 17 |
| Susan O'Connor | 11 |
| Suzanne Fleming | 9 |
| Giuseppe Ciaramella | 9 |
| Carole Ho | 8 |
| Courtney Wallace | 7 |
| J. Joung | 6 |
| Brian Busser | 5 |
| Manmohan Singh | 4 |
| David R. Liu | 3 |
| Francine Gregoire | 3 |
| Dana Levasseur | 3 |
| Nicole Gaudelli | 3 |
- Bourse
- Insiders
- Feng Zhang
- Connexions Sociétés
